• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The potential sudden shift in clinical research and epidemiology of cardiovascular diseases, caused by COVID-19.

作者信息

Pezel Théo, Lima Joao A C

机构信息

Cardiology Division, Department of Medicine, Johns Hopkins University, 600 North Wolfe Street, 21287-0409 Baltimore, MD, USA; Department of Cardiology, Lariboisière Hospital, AP-HP, Inserm UMRS 942, University of Paris, 75010 Paris, France.

Cardiology Division, Department of Medicine, Johns Hopkins University, 600 North Wolfe Street, 21287-0409 Baltimore, MD, USA.

出版信息

Arch Cardiovasc Dis. 2020 Jun-Jul;113(6-7):378-380. doi: 10.1016/j.acvd.2020.05.001. Epub 2020 Jun 19.

DOI:10.1016/j.acvd.2020.05.001
PMID:32586675
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7303640/
Abstract
摘要

相似文献

1
The potential sudden shift in clinical research and epidemiology of cardiovascular diseases, caused by COVID-19.由新冠病毒疾病（COVID-19）引起的心血管疾病临床研究和流行病学的潜在突然转变。
Arch Cardiovasc Dis. 2020 Jun-Jul;113(6-7):378-380. doi: 10.1016/j.acvd.2020.05.001. Epub 2020 Jun 19.
2
Crucial Conversations With Patients in the Era of COVID-19.COVID-19时代与患者的关键对话
Circulation. 2020 Jul 21;142(3):191-193. doi: 10.1161/CIRCULATIONAHA.120.047374. Epub 2020 May 6.
3
The Landscape of Cardiovascular Clinical Trials in the United States Initiated Before and During COVID-19.美国在新冠疫情之前及期间启动的心血管临床试验概况
J Am Heart Assoc. 2020 Sep 15;9(18):e018274. doi: 10.1161/JAHA.120.018274. Epub 2020 Jul 27.
4
Coronavirus disease 2019 infection and the cardiovascular system.2019冠状病毒病感染与心血管系统
J Cardiovasc Med (Hagerstown). 2020 Jun;21(6):403-405. doi: 10.2459/JCM.0000000000000980.
5
Rules for scientific progress while living with the COVID-19 Pandemic: from 'benchside' to 'fireside.'.与新冠疫情共存期间的科学进步规则：从“实验室”到“炉边” 。
Cancer Biol Ther. 2020 Jul 2;21(7):581-582. doi: 10.1080/15384047.2020.1747775. Epub 2020 Mar 30.
6
Recommendations for Cardiovascular Prevention During the Sars-Cov-2 Pandemic: An Executive Document by the Board of the Italian Society of Cardiovascular Prevention.2019冠状病毒病大流行期间心血管疾病预防建议：意大利心血管疾病预防协会理事会执行文件
High Blood Press Cardiovasc Prev. 2020 Oct;27(5):373-377. doi: 10.1007/s40292-020-00401-1. Epub 2020 Jul 30.
7
Spontaneous Major Hemorrhage in COVID-19 Patients: Another Brick in the Wall of SARS-CoV-2-Associated Coagulation Disorders?COVID-19患者的自发性大出血：是新型冠状病毒相关凝血障碍“这堵墙”上的又一块砖？
J Vasc Interv Radiol. 2020 Sep;31(9):1494-1496. doi: 10.1016/j.jvir.2020.06.010. Epub 2020 Jun 24.
8
[What I talk about when I talk about COVID-19].当我谈论新冠病毒时我在谈些什么
Laeknabladid. 2020 Sep;106(9):395. doi: 10.17992/lbl.2020.09.594.
9
Cardiovascular diseases, lipid-lowering therapies and European registries in the COVID-19 pandemic.心血管疾病、降脂疗法与新冠疫情期间的欧洲注册研究
Cardiovasc Res. 2020 Aug 1;116(10):e122-e125. doi: 10.1093/cvr/cvaa176.
10
Proposal of the French Society of Vascular Medicine for the prevention, diagnosis and treatment of venous thromboembolic disease in outpatients with COVID-19.法国血管医学协会关于COVID-19门诊患者静脉血栓栓塞性疾病预防、诊断和治疗的建议
J Med Vasc. 2020 Jul;45(4):210-213. doi: 10.1016/j.jdmv.2020.04.008. Epub 2020 Apr 27.

本文引用的文献

1
Health system, public health, and economic implications of managing COVID-19 from a cardiovascular perspective.从心血管角度管理新冠疫情对卫生系统、公共卫生及经济的影响。
Eur Heart J. 2020 Jul 14;41(27):2516-2518. doi: 10.1093/eurheartj/ehaa342.
2
The Obstacle Course of Reperfusion for ST-Segment-Elevation Myocardial Infarction in the COVID-19 Pandemic.新冠疫情下 ST 段抬高型心肌梗死再灌注治疗的障碍历程
Circulation. 2020 Jun 16;141(24):1951-1953. doi: 10.1161/CIRCULATIONAHA.120.047523. Epub 2020 Apr 21.
3
COVID-19-related myocarditis in a 21-year-old female patient.一名21岁女性患者的新型冠状病毒肺炎相关心肌炎
Eur Heart J. 2020 May 14;41(19):1859. doi: 10.1093/eurheartj/ehaa288.
4
COVID-19 in patients with cardiovascular diseases.心血管疾病患者中的新型冠状病毒肺炎
Arch Cardiovasc Dis. 2020 Apr;113(4):225-226. doi: 10.1016/j.acvd.2020.03.009. Epub 2020 Mar 31.
5
COVID-19 pandemic and cardiac imaging: EACVI recommendations on precautions, indications, prioritization, and protection for patients and healthcare personnel.新型冠状病毒肺炎大流行与心脏成像：欧洲心血管影像学会关于患者及医护人员预防措施、检查指征、优先次序及防护的建议
Eur Heart J Cardiovasc Imaging. 2020 Jun 1;21(6):592-598. doi: 10.1093/ehjci/jeaa072.
6
Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic.心血管考虑因素在 COVID-19 大流行期间的患者、医护人员和卫生系统。
J Am Coll Cardiol. 2020 May 12;75(18):2352-2371. doi: 10.1016/j.jacc.2020.03.031. Epub 2020 Mar 19.
7
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
8
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.基于对来自中国武汉的150名患者数据的分析得出的COVID-19相关死亡的临床预测因素。
Intensive Care Med. 2020 May;46(5):846-848. doi: 10.1007/s00134-020-05991-x. Epub 2020 Mar 3.
9
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.中国2019年冠状病毒病（COVID-19）疫情的特征及重要经验教训：来自中国疾病预防控制中心72314例病例报告的总结
JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.
10
Pathological findings of COVID-19 associated with acute respiratory distress syndrome.与急性呼吸窘迫综合征相关的新型冠状病毒肺炎的病理表现
Lancet Respir Med. 2020 Apr;8(4):420-422. doi: 10.1016/S2213-2600(20)30076-X. Epub 2020 Feb 18.